Acute Lymphocytic Leukemia
Oncology·MeSH: Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prevalence
30.0 / 100K
1 drug in development·1 company·5 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| KT-253 | Kymera Therapeutics, Inc. (KYMR) |
Frequently asked questions
How many drugs are in development for Acute Lymphocytic Leukemia?
BioSniper tracks 1 drug in development for Acute Lymphocytic Leukemia across 1 company.
How many clinical trials target Acute Lymphocytic Leukemia?
There are 5 clinical trials targeting Acute Lymphocytic Leukemia tracked by BioSniper.
What is the prevalence of Acute Lymphocytic Leukemia?
The estimated prevalence of Acute Lymphocytic Leukemia is approximately 30.0 per 100,000 population.
Deep-dive into Acute Lymphocytic Leukemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis